Found 22 matching trials
A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants PHASE1 The purpose of the study is to assess the tolerability, safety, and pharmac...
Show More Location
Clinical Pharmacology of Miami, Inc
Learn More & Join Trial
A Study of TAK-881 and HyQvia in Healthy Adults PHASE1 The main aim of this study is to understand how the body absorbs, processes...
Show More Learn More & Join Trial
Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia N/A The purpose of this registry is to acquire safety data (including assessmen...
Show More Location
QuintilesIMS Plaza Building
Learn More & Join Trial
Expanded Access to TAK-881 for People With Primary Immunodeficiency Diseases in the USA and Czech Republic N/A The expanded access program allows people to gain access to an unlicensed t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PHASE3 The main aim of this study is to evaluate the pharmacokinetic (PK) comparab...
Show More Location
HonorHealth Neurology
Learn More & Join Trial
A Study of TAK-881 in Healthy Adults PHASE1 The main aims of this study are to check for side effects from TAK-881 in h...
Show More Location
Clinical Pharmacology of Miami
Learn More & Join Trial
Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP PHASE3 Adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP...
Show More Location
Arizona Neuromuscular Research Center
Learn More & Join Trial
Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID PHASE3 The original purpose of the study is to assess the long-term safety, tolera...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases PHASE2 The main aim of this study is to evaluate the PK, safety, tolerability and ...
Show More Location
University of California Irvine Medical Center
Learn More & Join Trial
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects PHASE3 The purpose of the study is to acquire additional data on efficacy, safety,...
Show More Location
University of Alabama Medical Center
Learn More & Join Trial